InvestorsHub Logo

rayovacAAA

10/15/19 4:30 PM

#214686 RE: falconer66a #214684

Interestingly, no one has posted numbers or information that would invalidate my projections.




How does one invalidate a projection based on COMPLETE FANTASY?


ZERO EVIDENCE CURRENTLY EXISTS ANAVEX WILL BE APPROVED FOR ANY CNS INDICATION.











McMagyar

10/15/19 5:27 PM

#214691 RE: falconer66a #214684

Thanks Falconer..

ososilver

10/15/19 7:20 PM

#214698 RE: falconer66a #214684

Most excellent post...A proverbial "Fountain of Youth"

of the likes of Ponce de Leon!

mrplmer

10/15/19 8:53 PM

#214716 RE: falconer66a #214684

Great post Falconer

Jager997

10/15/19 9:35 PM

#214720 RE: falconer66a #214684

Falconer, Your thoughts on A2-73 treating diabetes?

tradeherpete

10/15/19 10:18 PM

#214727 RE: falconer66a #214684

Privately, I’ve diagramed how the Anavex molecules might work against a number of non-CNS diseases. I won’t post any of those here. To do so would simply prompt a bunch of “Ridiculous. Can’t be so!” pronouncements. But, Missling knows. In a year or two, after approval of one or two of the Anavex drugs, revenues will allow for expanded, diverse clinical trials in humans, against a variety of diseases and conditions.



The elder populations that will be receiving A2-73 will also have a host of other age related problems and if statistics show improvements in other pathologies, then it will be like a parent waiting for a child to see the light in a simple problem.

Will trials even be necessary?